exposing Parkinson's disease's voices and faces.

Published Date: 26 Apr 2023

One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.

Read Full News

Latest News

Fluctuations in Sleep Patterns Common in Schizophrenia

Variability in sleep efficiency and time in bed is increased in individuals at clinical high risk for psychosis or with schizophrenia spectrum disorders, new research shows.

Annual Wellness Visits May Help Flag Cognitive Issues

Annual wellness visits are linked to an increased chance of diagnosis of mild cognitive impairment.

Sleep Disorders Common in Medication Overuse Headache

Sleep disorders are more common in people with medication overuse headache than in those without the condition, with MOH treatment improving sleep, a study shows.

Psilocybin-Assisted Tx Shows Early Promise in Severe PTSD

Three quarters of veterans with severe, treatment-resistant PTSD achieve remission at 1 month after psilocybin-assisted therapy in a small pilot study.

Atogepant Outperforms Topiramate for Migraine Prevention

Atogepant shows better tolerability and efficacy than topiramate for migraine prevention in a phase 3b trial comparing the drugs.

Experimental Test Could Allow At-Home Autism Assessment

A novel adaptive test that quickly identifies autism with similar accuracy to conventional exams could soon be administered at home by parents in consultation with clinicians, a new study suggests.

Todays Updates

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

OA Tied to Arthritis AE Risk in ICI-Treated Patients

In patients with cancer receiving immune checkpoint inhibitor therapy, osteoarthritis is linked to the risk for inflammatory arthritis immune-related adverse events.

Stem Cell Transplant Linked to Longer Survival in CMML

Researchers evaluate the impact of allogeneic stem cell transplantation in chronic myelomonocytic leukemia across BLAST and BLAST-Mol clinical risk models.

Todays Updates

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

OA Tied to Arthritis AE Risk in ICI-Treated Patients

In patients with cancer receiving immune checkpoint inhibitor therapy, osteoarthritis is linked to the risk for inflammatory arthritis immune-related adverse events.

Stem Cell Transplant Linked to Longer Survival in CMML

Researchers evaluate the impact of allogeneic stem cell transplantation in chronic myelomonocytic leukemia across BLAST and BLAST-Mol clinical risk models.

Latest News

Variability in sleep efficiency and time in bed is increased in individuals at clinical high risk for psychosis or with schizophrenia spectrum disorders, new research shows.

Annual wellness visits are linked to an increased chance of diagnosis of mild cognitive impairment.

Sleep disorders are more common in people with medication overuse headache than in those without the condition, with MOH treatment improving sleep, a study shows.

Three quarters of veterans with severe, treatment-resistant PTSD achieve remission at 1 month after psilocybin-assisted therapy in a small pilot study.

Atogepant shows better tolerability and efficacy than topiramate for migraine prevention in a phase 3b trial comparing the drugs.

A novel adaptive test that quickly identifies autism with similar accuracy to conventional exams could soon be administered at home by parents in consultation with clinicians, a new study suggests.

News All Time

TBI History Tied to False-Negative Alzheimer’s Blood Test

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

p-Tau217 May Predict Cognitive Decline Years Before Symptoms

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

ENTF Stim Boosts Freedom From Disability Post-Stroke

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

FDA Neurology Roundup: June 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI Uncovers ‘Invisible’ Cortical Lesions in MS MRI Scans

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Deep Brain Stimulation Tied to Lower Mortality in PD

Deep brain stimulation is linked to reduced risks for mortality and institutionalization, and lower healthcare costs in adults with Parkinson’s disease, a study shows.

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

What Is Causing This Case of Sudden Aphasia?

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Neuropathy After Recreational Use of Laughing Gas

Clinicians should be aware of adverse effects of this increasingly popular drug

Alzheimer's Biomarkers Change After Tuberculosis Vaccination

BCG vaccine altered immune responses and modified amyloid-beta, study shows

Vitamin C and the Brain; Invisible MS Lesions Revealed; Profound Autism Definition

News and commentary from the world of neurology and neuroscience

Modified Amino Acid Improves Neurologic Symptoms in Rare Genetic Disorder

— Levacetylleucine succeeds in phase III trial of adults and kids with ataxia-telangiectasia

Third Molar Extraction: Benefit or Overtreatment?

Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Brain Risks Tied to High Ultraprocessed Food Intake

Longitudinal study links heavily processed food with a sharp increase in cognitive impairment

Recommended News For You

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Kate Middleton Announces Major Cancer Update

Prostate cancer therapies: AI-based image analysis detects early organ damage

Are patients with advanced cancer receiving treatment aligned with their goals?

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

Recommended Articles For You

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels  

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances 

Clinical Pharmacology of Tumor Microenvironment-Activated Prodrugs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

2.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

3.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

4.

Increased Exercise May Lower the Risk of Prostate Cancer.

5.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

1.

Erythropoietic Activity Biomarkers in Functional Hematology

2.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

3.

Cancer Prehabilitation and Functional Recovery Pathways: An Evidence-Based Review

4.

Decoding Granular Cell Tumor: What You Need to Know

5.

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

Should We Use DARA Up Front As First-Line Therapy in MM?

4.

Navigating the Complexities of Ph Negative ALL - Part IV

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot